Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.12
+0.04 (0.56%)
Aug 15, 2025, 10:43 AM - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $522.73 million as of August 15, 2025. Its market cap has decreased by -71.89% in one year.
Market Cap
522.73M
Enterprise Value
-331.50M
1-Year Change
-71.89%
Ranking
Category
Stock Price
$7.12
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $522.73M, an increase of 1.28%. That is a compound annual growth rate of 0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 519.80M | -60.54% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | 4.09B | 159.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |